Former Spotify monetization executive and tech operator, Andrew Bowers brings product-led growth experience to investor and advisory roles. He led ad product, partnerships and revenue initiatives at consumer internet companies, focusing on scaling digital advertising, platform economics and subscription conversion. Background combines product management and go-to-market execution with angel investments in media-tech and mobile apps. Market-relevant expertise in user monetization, adtech stacks and commercial partnerships for growth-stage digital businesses.
Former Spotify monetization executive and tech operator, Andrew Bowers brings product-led growth experience to investor and advisory roles. He led ad product, partnerships and revenue initiatives at consumer internet companies, focusing on scaling digital advertising, platform economics and subscription conversion. Background combines product management and go-to-market execution with angel investments in media-tech and mobile apps. Market-relevant expertise in user monetization, adtech stacks and commercial partnerships for growth-stage digital businesses.
Operator-investor approach focused on product-led monetization and scalable go-to-market execution. Prioritizes growth-stage media-tech, adtech and consumer apps where subscription conversion and ad stack optimization drive unit economics. Deploys concentrated seed-to-Series-A checks with follow-on reserve, coupling capital with hands-on product, partnerships and revenue playbooks. Underwrites opportunities by product-market fit, measurable ARPU expansion levers, and clear platform economics; time horizon favors accelerated scaling to monetization inflection and strategic exits.
Operator-investor approach focused on product-led monetization and scalable go-to-market execution. Prioritizes growth-stage media-tech, adtech and consumer apps where subscription conversion and ad stack optimization drive unit economics. Deploys concentrated seed-to-Series-A checks with follow-on reserve, coupling capital with hands-on product, partnerships and revenue playbooks. Underwrites opportunities by product-market fit, measurable ARPU expansion levers, and clear platform economics; time horizon favors accelerated scaling to monetization inflection and strategic exits.
| Trades 1263 | Longs Won 893/1263 70% | Profit Factor 15.6 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $299,063.67 |
| Average Win $93,193.2 | Best Trade (Aug 14) $8.66M | Sharpe Ratio -39.52 |
| Average Loss -$14,420.99 | Worst Trade (Aug 19) -$459,243 | Z-Score 9.47 (100%) |
| Commissions $0 | Avg. Trade Length 10m 3w | Expectancy $61,667.27 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 27,778 | 25,000 | 22,222 | 19,444 | 16,667 | 13,889 | 11,111 | 8,333 | 5,556 | 2,778 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 44,294 | $10.85M | $13.68M | - | $2.84M | 26.15% | -7.354% |
ABBV AbbVie Inc. | 1,023 | $257,448 | $256,711.62 | - | -$736.38 | -0.29% | -2.513% |
ABT Abbott Laboratories | 2,599 | $301,923.1 | $274,714.3 | - | -$27,208.8 | -9.01% | +0.085% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 6,803 | $482,448 | $511,925.75 | - | $29,477.75 | 6.11% | -0.172% |
ADP Automatic Data Processing Inc. | 1,732 | $387,881 | $461,508.7 | - | $73,627.7 | 18.98% | +0.982% |
AGG iShares Core U.S. Aggregate Bond ETF | 12,848 | $1.27M | $1.25M | - | -$21,510.55 | -1.69% | -0.256% |
AMAT Applied Materials, Inc. | 2,299 | $371,611.57 | $1.17M | - | $795,521.78 | 214.07% | +1.176% |
AMD Advanced Micro Devices, Inc. | 958 | $556,381 | $456,151.69 | - | -$100,229.31 | -18.01% | -1.904% |
AMGN Amgen Inc. | 2,213 | $678,653.84 | $852,359.08 | - | $173,705.24 | 25.6% | -0.64% |
AMZN Amazon.com Inc | 17,887 | $3.87M | $4.86M | - | $989,704.92 | 25.59% | +15.321% |
ANET Arista Networks, Inc. | 3,799 | $408,162.49 | $685,149.69 | - | $276,987.2 | 67.86% | +5.456% |
AOK iShares Core Conservative Allocation ETF | 7,621 | $290,048.49 | $311,851.32 | - | $21,802.83 | 7.52% | -0.049% |
AOM iShares Core 40/60 Moderate Allocation ETF | 10,857 | $484,908.7 | $532,861.58 | - | $47,952.88 | 9.89% | 0.0 |
ARKK ARK Innovation ETF Fund | 13,729 | $1.14M | $978,053.96 | - | -$160,088.49 | -14.07% | -2.277% |
ASML ASML Holding N.V. New York Registry Shares | 238 | $232,297.73 | $387,702 | - | $155,404.27 | 66.9% | -1.359% |
AVUV Avantis U.S. Small Cap Value ETF | 66,873 | $8.34M | $8.38M | - | $34,799.44 | 0.42% | +0.032% |
AXP American Express Company | 1,966 | $578,978.66 | $661,067.5 | - | $82,088.84 | 14.18% | -0.376% |
AZBO AllianzIM U.S. Large Cap Buffer20 Oct ETF | 6,605 | $257,595 | $272,390.2 | - | $14,795.2 | 5.74% | +0.365% |
AZN AstraZeneca PLC American Depositary Shares | 1,830 | $360,547.68 | $310,441.2 | - | -$50,106.48 | -13.9% | -0.992% |
BA Boeing Company | 2,389 | $446,904.78 | $516,358.46 | - | $69,453.68 | 15.54% | -2.155% |